Overall, these findings have important implications for the clinical and genetic study of families with cardiomyopathy, above all the findings of some TNNT2 mutations, which, given its demonstrated malignancy, should cause a change in the management of individuals in SCD prevention. The gene discussed is TNNT2; the disease is Schnyder corneal dystrophy.